Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
As of today, Illumina(ILMN) shares are valued at $128.97. The company's market cap stands at 19.72B, with a P/E ratio of 23.78.
On 2026-03-04, Illumina(ILMN) stock traded between a low of $128.60 and a high of $132.23. Shares are currently priced at $128.97, which is +0.3% above the low and -2.5% below the high.
The Illumina(ILMN)'s current trading volume is 1.31M, compared to an average daily volume of 2.4M.
During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $155.53 at its peak.
During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $155.53 at its peak.
ILMN News
In late February 2026, Illumina, Inc. launched its TruPath Genome whole‑genome workflow and expanded Illumina Laboratory Services to support Florida State Unive...
Illumina (NasdaqGS:ILMN) has launched TruPath Genome, a whole genome offering focused on higher accuracy, efficiency, and resolving complex genomic regions. Th...
Insiders have been trading these 5 stocks: ((ILMN)), ((SO)), ((GLW)), ((STX)) and ((MCHP)). Here is a breakdown of their recent trades and their value. CLO Sco...
Analyst ratings
43%
of 23 ratingsMore ILMN News
Illumina, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kyle Mikson CFA from Canaccord Genuity maintained a Hold rati...
TD Cowen analyst Dan Brennan says Roche (RHHBY) yesterday announced the consumables price for the Xpandomer-based nanopore sequencer, Axelios, at $150 per genom...
Illumina (ILMN) is back in focus for investors after recent trading moves, with the stock showing mixed performance across different time frames and a meaningfu...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.